
New Drug Combination Brings Hope for Treatment-Resistant Colon Cancer
In a groundbreaking advancement for metastatic colorectal cancer treatment, researchers from City of Hope have revealed promising results from a Phase 3 clinical trial examining a novel combination therapy targeting the elusive KRAS G12C mutation. This …